Timothy P. Lynch’s Stonepine Capital Portfolio: Top 5 Healthcare Stocks

4. Galapagos NV (NASDAQ:GLPG)

Stonepine Capital’s Stake Value: $12,848,000

Percentage of Stonepine Capital’s 13F Portfolio: 5.84%

Number of Hedge Fund Holders: 22

Galapagos NV (NASDAQ:GLPG) is a Belgian pharmaceutical research corporation that is engaged in the clinical stage of small molecule medicines aimed at treating multiple diseases including inflammation and fibrosis. Stonepine Capital owns 244,205 Galapagos NV (NASDAQ:GLPG) shares, worth $12.84 million as of the third quarter, representing 5.84% of the firm’s 13F portfolio. 

Oleg Nodelman’s EcoR1 Capital is the largest stakeholder of Galapagos NV (NASDAQ:GLPG), with an $82 million stake in the company. Overall, 22 hedge funds reported owning stakes in Galapagos NV (NASDAQ:GLPG), worth $342.5 million as per Insider Monkey’s Q3 database.